126 related articles for article (PubMed ID: 10997714)
1. Application of capillary electrophoresis in clinical chemistry: the clinical value of urinary modified nucleosides.
Liebich HM; Lehmann R; Xu G; Wahl HG; Häring HU
J Chromatogr B Biomed Sci Appl; 2000 Aug; 745(1):189-96. PubMed ID: 10997714
[TBL] [Abstract][Full Text] [Related]
2. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients.
Liebich HM; Xu G; Di Stefano C; Lehmann R
J Chromatogr A; 1998 Jan; 793(2):341-7. PubMed ID: 9474787
[TBL] [Abstract][Full Text] [Related]
3. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients.
Xu G; Liebich HM; Lehmann R; Müller-Hagedorn S
Methods Mol Biol; 2001; 162():459-74. PubMed ID: 11217356
[No Abstract] [Full Text] [Related]
4. Chromatographic, capillary electrophoretic and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of urinary modified nucleosides as tumor markers.
Liebich HM; Müller-Hagedorn S; Klaus F; Meziane K; Kim KR; Frickenschmidt A; Kammerer B
J Chromatogr A; 2005 Apr; 1071(1-2):271-5. PubMed ID: 15865203
[TBL] [Abstract][Full Text] [Related]
5. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography.
Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S
Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266
[TBL] [Abstract][Full Text] [Related]
6. Artificial neural network classification based on capillary electrophoresis of urinary nucleosides for the clinical diagnosis of tumors.
Zhao R; Xu G; Yue B; Liebich HM; Zhang Y
J Chromatogr A; 1998 Dec; 828(1-2):489-96. PubMed ID: 9916327
[TBL] [Abstract][Full Text] [Related]
7. A fast capillary electrophoresis method for separation and quantification of modified nucleosides in urinary samples.
Jiang Y; Ma Y
Anal Chem; 2009 Aug; 81(15):6474-80. PubMed ID: 19552424
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of urinary nucleosides and creatinine assay by capillary electrophoresis with solid phase extraction.
Szymańska E; Markuszewski MJ; Bodzioch K; Kaliszan R
J Pharm Biomed Anal; 2007 Sep; 44(5):1118-26. PubMed ID: 17590562
[TBL] [Abstract][Full Text] [Related]
9. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
[TBL] [Abstract][Full Text] [Related]
10. Determination of urinary nucleosides via borate complexation capillary electrophoresis combined with dynamic pH junction-sweeping-large volume sample stacking as three sequential steps for their on-line enrichment.
Rageh AH; Kaltz A; Pyell U
Anal Bioanal Chem; 2014 Sep; 406(24):5877-95. PubMed ID: 25069881
[TBL] [Abstract][Full Text] [Related]
11. Analysis of urinary nucleosides. II. Comparison of mass spectrometric methods for the analysis of urinary nucleosides.
Dudley E; Lemiere F; Van Dongen W; Langridge JI; El-Sharkawi S; Games DE; Esmans EL; Newton RP
Rapid Commun Mass Spectrom; 2001; 15(18):1701-7. PubMed ID: 11555869
[TBL] [Abstract][Full Text] [Related]
12. Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer.
Yang J; Xu G; Kong H; Zheng Y; Pang T; Yang Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):27-33. PubMed ID: 12383477
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.
Zheng YF; Kong HW; Xiong JH; Lv S; Xu GW
Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313
[TBL] [Abstract][Full Text] [Related]
14. Urinary modified nucleosides as tumor markers.
Dudley E; Lemiere F; Van Dongen W; Esmans E; El-Sharkawi AM; Games DE; Brenton AG; Newton RP
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):987-9. PubMed ID: 14565327
[TBL] [Abstract][Full Text] [Related]
15. Capillary electrophoresis-mass spectrometry for direct determination of urinary modified nucleosides. Evaluation of synthetic urine as a surrogate matrix for quantitative analysis.
Rodríguez-Gonzalo E; Hernández-Prieto R; García-Gómez D; Carabias-Martínez R
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():21-30. PubMed ID: 24212140
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS.
Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E
Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341
[TBL] [Abstract][Full Text] [Related]
17. Novel approach for developing urinary nucleosides profile by capillary electrophoresis-mass spectrometry.
Wang S; Zhao X; Mao Y; Cheng Y
J Chromatogr A; 2007 Apr; 1147(2):254-60. PubMed ID: 17336316
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of different warping methods for the analysis of CE profiles of urinary nucleosides.
Szymańska E; Markuszewski MJ; Capron X; van Nederkassel AM; Vander Heyden Y; Markuszewski M; Krajka K; Kaliszan R
Electrophoresis; 2007 Aug; 28(16):2861-73. PubMed ID: 17702069
[TBL] [Abstract][Full Text] [Related]
19. Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from uterine myoma and cervical cancer patients.
Kim KR; La S; Kim A; Kim JH; Liebich HM
J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(1):97-106. PubMed ID: 11318432
[TBL] [Abstract][Full Text] [Related]
20. Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients.
Xu G; Di Stefano C; Liebich HM; Zhang Y; Lu P
J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):307-13. PubMed ID: 10517352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
